Welcome, Guest: Login or Register My Cart (0)
March 05, 2005  

Semrock, Inc., and Invitrogen Subsidiary Molecular Probes Sign Supply Agreement for Fluorescence Filters


Rochester, N.Y. - Molecular Probes®, a wholly-owned subsidiary of Invitrogen Corporation (Nasdaq:IVGN) has signed an agreement with Semrock, Inc., the leading provider of high-performance optical filters, to offer Semrock's highly acclaimed BrightLine™ series of fluorescence filters in its worldwide catalog. This agreement provides customers with convenient access to industry-leading fluorescent probes and filters through the same supplier.

"We want to provide our customers with the best filters available, and Semrock's cutting-edge filter technology is rapidly setting a new standard in the industry," stated Vicki Singer, Molecular Probes' Director of Business Development.

Invitrogen is committed to being the leading provider of novel fluorescence-based labeling and detection solutions that advance scientific and biomedical research worldwide through its Molecular Probes business. Its extensive product line includes a wide range of fluorescent probes and biochemicals for research use in cell biology, molecular biology, proteomics, immunology, biochemistry and neuroscience.

"Working directly with the premier vendor of fluorescence dyes will allow us to provide better service to our common customer base. This relationship is a natural. By combining the vast expertise in biochemistry of Invitrogen's Molecular Probes group with Semrock's extensive knowledge of optics, we will be ideally positioned to jointly deliver highly optimized dye/filter combinations," said Victor Mizrahi, President and CEO of Semrock.

Semrock's BrightLine™ fluorescence filters provide the highest peak transmission for maximum brightness while simultaneously providing superior contrast for high specificity, and are made exclusively with dense hard-coating technology without any adhesives in the optical path. The exceptional optical performance of patented BrightLine filters is made possible by combining the most modern ion-beam sputtering deposition systems with Semrock's proprietary optical-coating technology. Fluorescence filters are widely used for applications including drug discovery, chemical analysis, DNA and RNA nucleotide sequencing, toxicology, and blood analysis.

 

###

 

About Semrock:
Semrock manufactures high-performance optical coatings and filters that are setting the standard in optical filters for the biotech and analytical instrumentation markets. Semrock products include the highly acclaimed BrightLine™ series of fluorescence filters for microscopy, flow cytometry and other fluorescence-based instrumentation, exceptional filters for Raman spectroscopy, and unique biomedical laser system optics. Semrock's innovative products are made possible by combining modern ion-beam sputtering with Semrock's proprietary technology. Founded in September 2000, Semrock is based in Rochester, New York, a well-known center of optics, and has sales offices throughout the United States. For additional information about Semrock, its products, and its team of international distributors, visit the company website at www.semrock.com.

About Invitrogen:
Invitrogen Corporation (Nasdaq: IVGN) provides products and services that support academic and government research institutions and pharmaceutical and biotech companies worldwide in their efforts to improve the human condition. The company provides essential life science technologies for disease research, drug discovery, and commercial bioproduction. Invitrogen's own research and development efforts are focused on breakthrough innovation in all major areas of biological discovery including functional genomics, proteomics, bioinformatics and cell biology – placing Invitrogen's products in nearly every major laboratory in the world. Founded in 1987, Invitrogen is headquartered in Carlsbad, California, and conducts business in more than 70 countries around the world. The company globally employs approximately 4,000 scientists and other professionals. For more information about Invitrogen, visit the company's web site at www.invitrogen.com.

Semrock Media Contact:
Amanda Valek-MacDonald
Semrock, a Unit of IDEX Corporation
amacdonald@idexcorp.com
585-594-7003

Invitrogen Media Contact:
Invitrogen Corporation
Greg Geissman
gregory.geissman@invitrogen.com
760-476-7032